Literature DB >> 2229494

Hypergammaglobulinemic purpura of Waldenström.

K A Finder1, M L McCollough, S L Dixon, A J Majka, W Jaremko.   

Abstract

Hypergammaglobulinemic purpura of Waldenström is characterized by hypergammaglobulinemia, recurring purpura, an elevated erythrocyte sedimentation rate, and the presence of rheumatoid factor indicative of circulating immune complexes. There is a significant association with autoimmune diseases, especially Sjögren's syndrome and lupus erythematosus. Hypergammaglobulinemic purpura is considered primary when there is no other associated disease or secondary when associated with other diseases, usually autoimmune. Immune derangements are fundamental in its pathogenesis, although its cause is still unknown. Therapy is unrewarding and is probably unnecessary for this usually benign condition. Three cases are presented that are representative of patients with hypergammaglobulinemic purpura.

Entities:  

Mesh:

Year:  1990        PMID: 2229494     DOI: 10.1016/0190-9622(90)70271-i

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 2.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

3.  Hypergammaglobulinemic purpura of Waldenström-Unusual and impressive case in a patient with myeloma: A case report.

Authors:  Celina DeBiasio; Janelle Cyr; Stephanie Petkiewicz; Steven J Glassman
Journal:  SAGE Open Med Case Rep       Date:  2022-03-22

Review 4.  Pigmented Purpuric Dermatoses: A Complete Narrative Review.

Authors:  Cristina B Spigariolo; Serena Giacalone; Gianluca Nazzaro
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

5.  Refractory Sjogrens syndrome: Is parotidectomy justified?

Authors:  Arjun Gurmeet Singh; Meenaxi V Umarani; Sidramesh Muttagi
Journal:  Natl J Maxillofac Surg       Date:  2019-11-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.